• Stuart Quin joins GHO Capital as Partner

    Stuart Quin joins GHO Capital as Partner
    Stuart Quin joins GHO Capital as PartnerFormer CEO of Medica Group Plc and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investmentsLondon, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.Stuart, who holds a PhD in Immunology, has nearly two decades o
  • Development Bank of Japan invests in 4BIO Capital’s Ventures III fund

    Development Bank of Japan invests in 4BIO Capital’s Ventures III fund
    Press ReleaseDevelopment Bank of Japan invests in 4BIO Capital’s Ventures III fund4BIO Ventures III targeting $200-300 million to unlock the treatments of the future by investing in advanced therapies and other emerging technologiesLONDON & TOKYO, 4 January 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, announces to

Follow @financialnwsUK on Twitter!